| Application no. and date | 10768162.9 (espacenet) (Federated) (European Patent Register), 20101014 | | Patent/reg. no. and date | DK/EP 2488515, 20170104 | | Publication date | 20120822 | | Priority no. and date | US 251378 P, 20091014 | | EP pub. no. and date |
EP 2488515 20120822 | | Effective date | | | Applicant/owner | Janssen Pharmaceutica NV, Turnhoutseweg 30
2340 Beerse, BE | | Applicant ref. no. | P60651DK01 | | Inventor | FARINA, Vittorio, c/o Turnhoutseweg 30
B-2340 Beerse, BE,
LEMAIRE, Sebastien, Francois Emmanuel, c/o Turnhoutseweg 30
B-2340 Beerse, BE,
HOUPIS, Ioannis, N., c/o Turnhoutseweg 30
B-2340 Beerse, BE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07D 409/10 (2006.01) , C07D 409/14 (2006.01) , C07F 3/06 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLINGEN AF FORBINDELSER DER ER ANVENDELIGE SOM INHIBITORER AF SGLT2 | | Int. application no. | US2010052598 | | Int. publication no. | WO2011047113 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
